Qube Research & Technologies (QRT)
GILD icon

Qube Research & Technologies (QRT)’s Gilead Sciences GILD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.95M Buy
62,900
+17,700
+39% +$2.33M 0.01% 1404
2026
Q1 		$6.3M Sell
45,200
-8,300
-16% -$1.16M 0.01% 1543
2025
Q4 		$6.57M Buy
53,500
+19,900
+59% +$2.42M 0.01% 1606
2025
Q3 		$3.73M Sell
33,600
-238,800
-88% -$27.1M ﹤0.01% 1923
2025
Q2 		$30.2M Sell
272,400
-1,047,000
-79% -$111M 0.03% 678
2025
Q1 		$148M Buy
1,319,400
+1,282,900
+3,515% +$132M 0.17% 140
2024
Q4 		$3.37M Buy
36,500
+2,700
+8% +$243K ﹤0.01% 1674
2024
Q3 		$2.83M Sell
33,800
-425,700
-93% -$32.5M ﹤0.01% 1619
2024
Q2 		$31.5M Buy
459,500
+342,100
+291% +$22.8M 0.05% 440
2024
Q1 		$8.6M Sell
117,400
-120,100
-51% -$9.24M 0.01% 930
2023
Q4 		$19.2M Buy
237,500
+61,000
+35% +$4.75M 0.04% 528
2023
Q3 		$13.2M Buy
176,500
+38,000
+27% +$2.92M 0.03% 535
2023
Q2 		$10.7M Buy
+138,500
New +$11M 0.04% 520

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GILD Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Gilead Sciences (GILD) stake by 2,449% in Q2 2026, buying an estimated $391M and bringing the position to 3,086,166 shares worth $390M. The position accounts for 0.36% of the portfolio, ranked #37.

Qube Research & Technologies (QRT) first reported a position in GILD in Q1 2018 and has held it in 29 quarters since. The position peaked at $536M in Q3 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Qube Research & Technologies (QRT) held 3,086,166 shares of Gilead Sciences worth $390M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 2,965,114 Gilead Sciences shares in Q2 2026, an estimated $391M.
  • Gilead Sciences made up 0.36% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #37 holding.
  • Qube Research & Technologies (QRT) first reported a position in Gilead Sciences in Q1 2018 and has held it in 29 quarters since.
  • Qube Research & Technologies (QRT)'s Gilead Sciences position peaked at $536M in Q3 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.